Macerich is a fully integrated, self-managed, and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich's portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, D.C. corridor. Developing and managing properties that serve as community cornerstones, Macerich currently owns 45 million square feet of real estate consisting primarily of interests in 41 retail centers. Macerich is firmly dedicated to advancing environmental goals, social good and sound corporate governance. A recognized leader in sustainability, Macerich has achieved a #1 Global Real Estate Sustainability Benchmark (GRESB) ranking for the North American retail sector for ten consecutive years (2015-2024).

Macerich Company (The)

An update from Diamedica Therapeutics ( ($DMAC) ) is now available. DiaMedica Therapeutics Inc. held its 2026 Annual General Meeting of Shareholder...

DiaMedica Shareholders Approve Governance, Compensation and Incentive Plan

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Motorola Solutions (MSI), Unusual Machines Inc. (UMA...

Analysts’ Top Technology Picks: Motorola Solutions (MSI), Unusual Machines Inc. (UMAC)

Macfarlane ( ($GB:MACF) ) just unveiled an update. Macfarlane Group has continued its ongoing share buyback programme with the purchase and cancell...

Macfarlane buys back 75,000 shares, cutting share count to 156.1m

Needham analyst Austin Bohlig reiterated a Buy rating on Unusual Machines Inc. today and set a price target of $22.00. Bohlig covers the Technology...

Unusual Machines Inc. (UMAC) Gets a Buy from Needham

The latest announcement is out from Melar Acquisition Corp. I Class A ( ($MACI) ). On May 8, 2026, Melar Acquisition Corp. I and Melar Capital Grou...

Melar Acquisition Enters Intercreditor Agreement for Everli Deal

An announcement from Macerich ( ($MAC) ) is now available. On May 13, 2026, The Macerich Company completed a public offering of 22,080,000 shares o...

Macerich Completes Equity Offering to Fund Mall Acquisition

Melar Acquisition Corp. I Class A ( ($MACI) ) has provided an update. Melar Acquisition Corp. I, a Cayman Islands-incorporated SPAC listed on Nasda...

Melar Acquisition Schedules Extraordinary General Meeting to Meet Nasdaq

In a report released today, Matthew Caufield from H.C. Wainwright reiterated a Buy rating on Diamedica Therapeutics, with a price target of $12.00....

H.C. Wainwright Keeps Their Buy Rating on Diamedica Therapeutics (DMAC)

Analysts fell to the sidelines weighing in on Realty Income (O) and Macerich (MAC) with neutral ratings, indicating that the experts are neither bu...

Analysts Offer Insights on Real Estate Companies: Realty Income (O) and Macerich (MAC)

In a report released today, Greg McGinniss from Scotiabank maintained a Buy rating on Macerich, with a price target of $22.00. McGinniss covers the...

Scotiabank Sticks to Its Buy Rating for Macerich (MAC)

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Dexus (DEXSF) and Macerich (MAC). Dexus (DEXSF) J...

Analysts Conflicted on These Real Estate Names: Dexus (OtherDEXSF) and Macerich (MAC)

Macerich ( ($MAC) ) has shared an update. For the first quarter ended March 31, 2026, Macerich narrowed its net loss to $36.4 million, or $0.14 per...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MAC	$22.49	+1.44%	1.97M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MAC	$22.49	+1.4%	1.97M
3
4
5
6

MAC

MAC

No Data Available

Get Macerich Company (The) Data in Excel

Get Macerich Company (The) Data in Excel